News & Insights
In June 2016, Signet Accel had the honor of attending the National Cancer Moonshot Summit at Howard University, an initiative created under President Obama. One year later, the administration has changed and our healthcare system may as well—but former Vice President Joe Biden’s commitment to bring more data to the fight against cancer remains.
We asked healthcare IT and informaticists three simple questions. Here’s what we learned.
Seasoned executive Brenda Berry joins fast-growing healthcare software and services company; charged with leading and expanding national sales team in continued growth trajectory.
Value-based care is a critical goal, but one that can be complex to operationalize. And yet, it is well worth striving to achieve. Getting there requires a connected healthcare system that does not yet fully exist. I recently collaborated with colleagues and the American Medical Informatics Association to co-author a paper detailing this gap—the chasm between our current health IT ecosystem and the ecosystem that we need to solidify—a crack that must be closed if true value-based care and a learning health system are to be realized.
The fields of healthcare and life science are experiencing massive change, due to economic, policy and technological factors. At their core, the shifts center around the pursuits of precision medicine and value-based care.
EHR adoption rates are nearing 100 percent, yet we see a steady stream of headlines reporting dissatisfaction. Physicians are demanding more from EHRs—and patients want more, too. While there is ample opinion on the current effectiveness of EHRs, we can all agree that EHRs have room to improve. Looking ahead, we envision four key ways in which EHRs could do more and further advance quality of treatment and care.
It’s time to bridge the gap with Avec® and experience discovery at unprecedented speeds.
As CMO, Dr. Embi works across the organization to ensure our technologies address the driving issues and challenges of both researchers and physicians.
"We’re providing physicians and researchers the ability to view, analyze and experiment with aggregated data from disparate sources on a global scale. If there’s any way that we can improve on that process, and increase our clients’ speed of discovery, we are going to do it," said CEO John Raden.
The search for true interoperability can be time consuming, frustrating, and confusing. Wide claims are often made about data integration solutions, only to later find they aren’t truly interoperable—and the chatter at HIMSS will be no different. The best way to ensure a satisfying conference experience is to pull the plug on the propaganda and get prepared.
Cut through the clutter by using the three C’s of true interoperability as your guide: care, collaboration and cost.
Avec® securely connects disparate clinical trial and health data among clinical research networks—accelerating discover
In the fourth video in our series we talk about what drives our work each day: the human impact of Avec®. In the HIT industry, it’s easy to hone in on the large amounts of disparate data in need of integration and lose sight of its origin. But at Signet Accel, true interoperability is about more than code. Every piece of data represents a friend, loved one, family member or a colleague in need of or receiving care.
By Kimberley Ferguson, Executive Vice President, Sales & Marketing
Will we be asking our doctors for Watson by name? IBM is counting on it.
By John Raden, Chief Executive Officer
Are confidentiality, privacy, security and sharing incompatible goals?
Avec® creators Dr. Philip Payne and Dr. Peter Embi discuss true interoperability in the second video of our four-part series exploring precision medicine, our unique approach to solving the interoperability problem, and the human impact of Avec®.
Alliance provides unprecedented speed and accuracy to big data integration and discovery in healthcare industry.
Avec® creators Dr. Philip Payne and Dr. Peter Embi discuss true interoperability in the first of our four-part series exploring precision medicine, our unique approach to solving the interoperability problem, and the human impact of Avec®.
As CSO, Dr. Payne leads Avec® product development, supports our clients in solution strategy and development, and directs ongoing thought leadership for the company.
Healthcare Tech Outlook names Signet Accel among the year’s most promising healthcare analytics solution providers for its Avec® platform.
As healthcare professionals, we know that every data point presents an opportunity to learn and improve care. We want to integrate and share data. Yet often, we don’t. We’re standing at the precipice of the healthcare information technology and big data information age, with data security concerns as one of the most pressing issues in the modern healthcare-computing environment. And it’s impeding our progress.
Did you know your analytics tools are only as good as the data they can access? In this month's Healthcare Tech Outlook, CEO John Raden shares how Avec® succeeds in data integration where others fail. It's time to start seeing the whole picture of your data.
Nation’s third-largest cancer hospital looks to Avec® to enable data capture, sharing and matching in a cancer research information exchange spanning multiple cancer centers nationwide.
Billions have been invested to capture and store patient data, resulting in the creation of massive quantities of healthcare data—more today than at any point in history. Yet, an estimated 80% of that data remains unstructured, and therefore, locked and inaccessible.
Signet Accel is among 350 researchers and companies invited to attend the daylong conference hosted by Vice President Joe Biden on the campus of Howard University.
"Our roots are in cancer research...an invitation to attend the Cancer Moonshot Summit alongside our country’s brightest medical minds is an honor and testament to our commitment to data sharing through true interoperability in healthcare.”
John Raden, Signet Accel CEO
From Healthcare IT News: "Deputy National Coordinator for Health IT Jon White, MD, says universities are playing a key role in the development of interoperable healthcare systems.
Through the lens of precision medicine, all disease, no matter how common, is rare disease.
By Peter J. Embi, MD, MS, FACP, FACMI, Co-founder Signet Accel
Practicing medicine today is increasingly reliant on the documentation, retrieval and use of vast amounts of clinical data. We manage medical information with computers, and electronic health records (and the time we spend on them) have become ubiquitous in our practices. The challenge, now, is to use it—fully and responsibly—so we might realize the potential of these rapidly-growing amounts of health data. Our aim is not only to improve care, but also to advance biomedical research and discovery, so that we can take better care of patients both now and into the future. Achieving this requires that we collect, integrate and analyze data, often across sites separated by geography and technology.
By Dr. Philip R. O. Payne, PhD, FACMI, Co-founder Signet Accel
There have been a variety of publications and debates over the past several years arguing for the adoption of lessons learned from the private sector in order to increase the speed, scale, and scope of innovation in the healthcare and life sciences research communities. At their core, these arguments speak to the need to increase the agility and data-centricity of investigative efforts that seek to develop and disseminate new biomedical knowledge. However, when considering such a charge, a number of important questions come to mind, specifically: 1) can we map the role of a researcher to that of an entrepreneur, as one would find in the private sector; and 2) what are the foundational resources needed for such researchers to pursue their activities in a manner that is analogous to entrepreneurs in the private sector?
The biopharmaceutical industry is under tremendous pressure to deliver more robust research methodologies, investigate new treatments, and better understand (and predict) interactive affects for those with comorbidities and concomitant treatments. Yet, at the same time, an estimated 80% of healthcare data remains unstructured, and therefore locked and inaccessible.
COLUMBUS, Ohio--Signet Accel, a software and services company specializing in data integration and harmonization, today announced a partnership with online training provider Neunoia. Signet Accel customers can now access custom-built online training modules, on demand, from any location. E-learning with Neunoia will provide Signet Accel clients with convenient and thorough online training as they employ Avec®, Signet Accel’s commercial federated data integration platform that delivers true interoperability to big data in healthcare.
From Healthcare IT News: "LAS VEGAS – Signet Accel has launched Avec®, a commercial federated data integration platform designed to offer interoperability to healthcare organizations, the company announced at HIMSS16.
Avec® enables analysis of complex, distributed healthcare data in a manner that is secure and protects the ownership and control of data at every site, Signet Accel said. It does not require changes in the process of collecting data, the manner in which data is stored, where data is stored or how data is structured, the vendor added."
The search for true interoperability can be time consuming, frustrating, and more often than not, confusing. Wide claims are often made about interoperability solutions, only to later find they aren’t truly interoperable. Oversold and under- delivered may be the industry norm, but it’s not a certainty. The best way to ensure you’re pleased with your interoperability solution is to ask the right questions from the start. Consider the below a primer on the three C’s to true interoperability: care, collaboration and cost.
In four short days, a small city will be born in Las Vegas. More than 40,000 health IT professionals, clinicians, executives and vendors will gather to network and learn with their peers from around the world at the Healthcare Information and Management Systems Society (HIMSS) Exhibition and Conference.
COLUMBUS, Ohio--Software and services company Signet Accel announced today the official launch of Avec®, its commercial federated data integration platform delivering true interoperability to healthcare. Signet Accel will debut Avec® in Booth 12550 at the 2016 Healthcare Information and Management Systems Society (HIMSS) Conference and Exhibition, commencing February 29 in Las Vegas.
Our CEO, John Raden, left Chicago for Columbus to deliver true interoperability to healthcare via our Avec® platform. But the great qualities of our city, and its burgeoning health IT community, have been a welcome bonus.
For more than a decade, healthcare interoperability has been top of mind for IT leaders, practitioners, investigators and administrators. Tens of billions of dollars have been spent enabling the capture and storage of data, with the end goal of utilizing it to the benefit of patients. And still, we wait.
On October 6th, 2015, the Office of the National Coordinator for Health Information Technology (ONC) released its 10-year plan for a connected healthcare ecosystem.
We opened our doors and welcomed friends and colleagues at an open house to celebrate our new office in downtown Columbus. We gave tours of the space, clinked our glasses, and kicked off the holiday season with gratitude for a successful 2015. A big thanks to all who joined us!
COLUMBUS, Ohio--Signet Accel, a software and services company specializing in data integration and harmonization, announced today it has been selected as a finalist in the 2015 Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher of FierceHealthIT, FierceHealthcare, and FierceMobileHealthcare.
COLUMBUS, Ohio--Signet Accel, a software and services company specializing in data integration and harmonization, today announced a partnership with Predixion Software, a developer of cloud-based advanced analytics software. Signet Accel customers can now leverage the power of Predixion Insight™ for real-time, predictive analytics at the point of decision to improve outcomes. The combination of Signet Accel’s federated data integration platform, Avec®, and Predixion Insight™ will provide clients access to the full data lifecycle, from data integration with true interoperability, to real-time predictive analytics.
COLUMBUS, Ohio--Signet Accel announced today that John Raden has joined the company as chief executive officer. As a software and services company specializing in data integration and harmonization, Signet Accel brings true interoperability in big data and increased speed of discovery to translational medicine. With more than 15 years’ experience in healthcare and technology, Raden will lead Signet Accel in its continued expansion and growing portfolio of national and international clients.
Pardon the dust…we’ve moved downtown! Signet Accel doubled its footprint with a move to the Brewery District in downtown Columbus, Ohio. The move gives us 6,000 square feet of urban office space and a location befitting our place in the Columbus tech scene. It’s a welcoming space close to the amenities of downtown, less than five miles from The Ohio State University, and it’s an inspiring place to come to work each day. Visit us at 585 South Front Street.
“Ohio State University and Signet Enterprises in Akron have partnered to launch a software company they say will help health care organizations share data easily without the costs and difficulties of centralizing such information. Researchers within Ohio State's department of biomedical informatics developed the technologies involved with the new venture over the last decade.”
COLUMBUS, Ohio – The Ohio State University today announced the signing of an exclusive worldwide agreement with a new company formed by Signet Enterprises: Signet Accel LLC. The new company will license a portfolio of cutting-edge Ohio State-developed software technologies for health care data sharing and advanced analytics through the Ohio State Innovation Foundation.